D. E. Shaw & Co., Inc. Invitae Corp Transaction History

D. E. Shaw & Co., Inc.

$107 Billion
Q3 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$0.42 - $0.72 $1.1 Million - $1.89 Million	2,629,153 Added 595.43%	3,070,708 $1.93 Million
Q3 2023 Nov 14, 2023	SELL	$0.6 - $1.53 $862,613 - $2.2 Million	-1,437,689 Reduced 76.5%	441,555 $264,000
Q2 2023 Aug 14, 2023	BUY	$1.05 - $1.63 $1.19 Million - $1.86 Million	1,138,082 Added 153.55%	1,879,244 $2.12 Million
Q1 2023 May 15, 2023	SELL	$1.2 - $2.73 $18,110 - $41,201	-15,092 Reduced 2.0%	741,162 $1 Million
Q4 2022 Feb 14, 2023	BUY	$1.71 - $3.61 $1.29 Million - $2.73 Million	756,254 New	756,254 $1.41 Million
Q2 2022 Aug 15, 2022	BUY	$2.13 - $9.01 $7.72 Million - $32.6 Million	3,623,673 Added 1452.0%	3,873,237 $9.45 Million
Q1 2022 May 16, 2022	BUY	$6.28 - $15.59 $1.08 Million - $2.68 Million	172,070 Added 222.04%	249,564 $1.99 Million
Q4 2021 Feb 14, 2022	BUY	$14.7 - $28.67 $955,588 - $1.86 Million	65,006 Added 520.55%	77,494 $1.18 Million
Q2 2021 Aug 16, 2021	SELL	$26.09 - $40.4 $631,325 - $977,599	-24,198 Reduced 65.96%	12,488 $421,000
Q1 2021 May 17, 2021	SELL	$33.06 - $56.93 $25.7 Million - $44.2 Million	-776,400 Reduced 95.49%	36,686 $1.4 Million
Q4 2020 Feb 16, 2021	BUY	$39.09 - $57.4 $22.5 Million - $33 Million	575,180 Added 241.77%	813,086 $34 Million
Q3 2020 Nov 16, 2020	BUY	$28.43 - $44.67 $1.97 Million - $3.09 Million	69,181 Added 41.0%	237,906 $10.3 Million
Q2 2020 Aug 14, 2020	BUY	$11.71 - $30.29 $1.98 Million - $5.11 Million	168,725 New	168,725 $5.11 Million
Q4 2019 Feb 14, 2020	SELL	$15.02 - $20.57 $184,370 - $252,496	-12,275 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$18.85 - $27.5 $1.63 Million - $2.38 Million	-86,537 Reduced 87.58%	12,275 $237,000
Q2 2019 Aug 14, 2019	SELL	$17.37 - $26.27 $10.5 Million - $15.9 Million	-603,687 Reduced 85.93%	98,812 $2.32 Million
Q1 2019 May 15, 2019	BUY	$10.65 - $25.75 $467,300 - $1.13 Million	43,878 Added 6.66%	702,499 $16.5 Million
Q4 2018 Feb 14, 2019	BUY	$9.26 - $16.38 $1.45 Million - $2.56 Million	156,146 Added 31.08%	658,621 $7.28 Million
Q3 2018 Nov 14, 2018	BUY	$7.54 - $18.31 $3.79 Million - $9.2 Million	502,475 New	502,475 $8.41 Million
Q1 2018 May 15, 2018	SELL	$4.69 - $10.05 $443,364 - $950,066	-94,534 Closed	0 $0
Q4 2017 Feb 14, 2018	SELL	$7.86 - $9.99 $511,363 - $649,939	-65,059 Reduced 40.77%	94,534 $858,000
Q3 2017 Nov 14, 2017	BUY	$8.89 - $10.4 $1.42 Million - $1.66 Million	159,593	159,593 $1.5 Million

Others Institutions Holding NVTA

# of Institutions

Shares Held

1.92M

Call Options Held

Put Options Held

View Full List

About Invitae Corp

Ticker NVTA
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 235,266,000
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...

More about NVTA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.

Account